Suggested management of immunocompromized kidney patients suffering from SARS

The treatment of severe acute respiratory syndrome (SARS) is still empirical and controversial. Herein we report our experience in treating approximately 40 SARS children and adolescents. Treatment of SARS kidney patients is limited. Paediatric nephrologists should be on the alert for SARS in order...

Descripción completa

Detalles Bibliográficos
Autor principal: Chiu, Man-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2003
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087636/
https://www.ncbi.nlm.nih.gov/pubmed/14663579
http://dx.doi.org/10.1007/s00467-003-1325-8
_version_ 1783509371889647616
author Chiu, Man-Chun
author_facet Chiu, Man-Chun
author_sort Chiu, Man-Chun
collection PubMed
description The treatment of severe acute respiratory syndrome (SARS) is still empirical and controversial. Herein we report our experience in treating approximately 40 SARS children and adolescents. Treatment of SARS kidney patients is limited. Paediatric nephrologists should be on the alert for SARS in order to care for immunocompromised patients. Precautions should be made for both staff and patients with protective measures for infection control.
format Online
Article
Text
id pubmed-7087636
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70876362020-03-23 Suggested management of immunocompromized kidney patients suffering from SARS Chiu, Man-Chun Pediatr Nephrol Editorial Commentary The treatment of severe acute respiratory syndrome (SARS) is still empirical and controversial. Herein we report our experience in treating approximately 40 SARS children and adolescents. Treatment of SARS kidney patients is limited. Paediatric nephrologists should be on the alert for SARS in order to care for immunocompromised patients. Precautions should be made for both staff and patients with protective measures for infection control. Springer-Verlag 2003-10-24 2003 /pmc/articles/PMC7087636/ /pubmed/14663579 http://dx.doi.org/10.1007/s00467-003-1325-8 Text en © IPNA 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Editorial Commentary
Chiu, Man-Chun
Suggested management of immunocompromized kidney patients suffering from SARS
title Suggested management of immunocompromized kidney patients suffering from SARS
title_full Suggested management of immunocompromized kidney patients suffering from SARS
title_fullStr Suggested management of immunocompromized kidney patients suffering from SARS
title_full_unstemmed Suggested management of immunocompromized kidney patients suffering from SARS
title_short Suggested management of immunocompromized kidney patients suffering from SARS
title_sort suggested management of immunocompromized kidney patients suffering from sars
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087636/
https://www.ncbi.nlm.nih.gov/pubmed/14663579
http://dx.doi.org/10.1007/s00467-003-1325-8
work_keys_str_mv AT chiumanchun suggestedmanagementofimmunocompromizedkidneypatientssufferingfromsars

Ejemplares similares